Nirmatrelvir/ritonavir treatment in sars-cov-2 positive kidney transplant recipients – a case series with four patients

HIGHLIGHTS

• who: Johanna Schneider from the We retrospectively analysed the first four kidney transplant patients with COVID-19, who received treatment with nirmatrelvir/ritonavir at the Medical Centre of the University of Freiburg, GermanyWritten informed consent was obtained from all patients presented. The need for an ethics approval was waived by the ethics committee of the Freiburg Medical Centre. Clinical data were collected from patient records. All patients were in inpatient care. GraphPadu2122 Prism Version , software (GraphPad Software, San Diego, CA) was used for diagram preparation. Patients #1, #, and #, were >, year post-transplantation (Table, ). Patient #, received an ABO . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.